Hong SP - Search Results

1

An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells.

Bae JA, Yoon S, Park SY, Lee JH, Hwang JE, Kim H, Seo YW, Cha YJ, Hong SP, Kim H, Chung IJ, Kim KK. Bae JA, et al. Among authors: hong sp. Clin Cancer Res. 2014 Aug 1;20(15):4115-28. doi: 10.1158/1078-0432.CCR-13-2863. Epub 2014 Jun 3. Clin Cancer Res. 2014. PMID: 24893630

2

Chiral separation of beta-blockers after derivatization with (-)-menthyl chloroformate by reversed-phase high performance liquid chromatography.

Kim KH, Choi PW, Hong SP, Kim HJ. Kim KH, et al. Among authors: hong sp. Arch Pharm Res. 1999 Dec;22(6):608-13. doi: 10.1007/BF02975333. Arch Pharm Res. 1999. PMID: 10615867

3

Chiral purity test of metoprolol enantiomer after derivatization with (-)-menthyl chloroformate by reversed-phase high performance liquid chromatography.

Kim KH, Choi PW, Hong SP, Kim HJ. Kim KH, et al. Among authors: hong sp. Arch Pharm Res. 1999 Dec;22(6):614-8. doi: 10.1007/BF02975334. Arch Pharm Res. 1999. PMID: 10615868

4

Chiral separation of the enantiomers of metoprolol and its metabolites by high performance liquid chromatography.

Kim KH, Shin SD, Lee JH, Lee SC, Kang JS, Mar W, Hong SP, Kim HJ. Kim KH, et al. Among authors: hong sp. Arch Pharm Res. 2000 Jun;23(3):230-6. doi: 10.1007/BF02976450. Arch Pharm Res. 2000. PMID: 10896053

5

Determination of terbutaline enantiomers in human plasma by coupled achiral-chiral high performance liquid chromatography.

Kim KH, Kim HJ, Hong SP, Shin SD. Kim KH, et al. Among authors: hong sp. Arch Pharm Res. 2000 Oct;23(5):441-5. doi: 10.1007/BF02976568. Arch Pharm Res. 2000. PMID: 11059819

6

Chiral separation of beta-blockers after derivatization with (-)-alphamethoxy-alpha-(trifluoromethyl)phenylacetyl chloride by gas chromatography.

Kim KH, Lee JH, Ko MY, Hong SP, Youm JR. Kim KH, et al. Among authors: hong sp. Arch Pharm Res. 2001 Oct;24(5):402-6. doi: 10.1007/BF02975183. Arch Pharm Res. 2001. PMID: 11693539

7

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

Hong SP, Wen J, Bang S, Park S, Song SY. Hong SP, et al. Int J Cancer. 2009 Nov 15;125(10):2323-31. doi: 10.1002/ijc.24573. Int J Cancer. 2009. PMID: 19598259

8

The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.

Hong SP, Min BS, Kim TI, Cheon JH, Kim NK, Kim H, Kim WH. Hong SP, et al. Eur J Cancer. 2012 May;48(8):1235-43. doi: 10.1016/j.ejca.2011.10.005. Epub 2011 Nov 7. Eur J Cancer. 2012. PMID: 22071131

9

Clinical outcomes and factors related to resectability and curability of EMR for early colorectal cancer.

Park JJ, Cheon JH, Kwon JE, Shin JK, Jeon SM, Bok HJ, Lee JH, Moon CM, Hong SP, Kim TI, Kim H, Kim WH. Park JJ, et al. Among authors: hong sp. Gastrointest Endosc. 2011 Dec;74(6):1337-46. doi: 10.1016/j.gie.2011.07.069. Gastrointest Endosc. 2011. PMID: 22136778

10

Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.

Park JJ, Kwon JH, Oh SH, Choi J, Moon CM, Ahn JB, Hong SP, Cheon JH, Kim TI, Kim H, Kim WH. Park JJ, et al. Among authors: hong sp. Mol Carcinog. 2014 Feb;53 Suppl 1:E1-10. doi: 10.1002/mc.21971. Epub 2012 Oct 12. Mol Carcinog. 2014. PMID: 23065858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

820 results

Search Page

Filters